Maxalt Max

Rizatriptan, the active ingredient in Maxalt Max, is a Triptan presented as an oral tablet for oral use. It is indicated for the acute treatment of migraine attacks in adult patients, providing relief from headache and associated symptoms such as nausea, photophobia, and phonophobia.

GNH USA supplies Maxalt Max as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support import and distribution across multiple regions.

Rizatriptan is a Triptan used in the migraine pathway to alleviate acute attacks.

Migraine with aura: provides rapid relief of headache and associated symptoms. Migraine without aura: reduces severity and duration of attacks. Acute migraine attacks: alleviates headache, nausea, photophobia, and phonophobia during an episode.

Rizatriptan may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Chest tightness or pressure - Tingling or numbness in the face or extremities - Dizziness or light‑headedness - Nausea or abdominal discomfort - Fatigue or drowsiness - Dry mouth

Serious or Rare Side Effects: - Coronary vasospasm or myocardial infarction - Serotonin syndrome, especially with serotonergic drugs - Severe allergic reactions (anaphylaxis, angioedema) - Hypertension or hypertensive crisis - Cardiac arrhythmias - Persistent visual disturbances

Before prescribing Rizatriptan, clinicians should evaluate patient history and potential risk factors.

Assess cardiovascular history: avoid use in patients with coronary artery disease, uncontrolled hypertension, or recent myocardial infarction. Review concomitant serotonergic therapy: monitor for signs of serotonin syndrome. Consider age and hepatic function: dose adjustments may be needed in elderly or hepatic impairment. Avoid use during pregnancy unless clearly needed: safety data are limited. Do not operate heavy machinery if experiencing dizziness or visual changes. Store at room temperature: keep in the original container, protect from moisture and heat.

Rizatriptan can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - MAO inhibitors: risk of severe hypertension and serotonin syndrome. - Other triptans or ergot alkaloids: increased risk of vasospasm and cardiovascular events. - SSRIs, SNRIs, or other serotonergic agents: heightened potential for serotonin syndrome.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase rizatriptan plasma levels. - Antihypertensive agents: possible additive blood pressure effects. - Oral contraceptives: may slightly reduce efficacy of migraine relief.